Adverse events during testosterone replacement therapy in 95 young hypogonadal thalassemic men

Medicine and Dentistry

• Thalassemia Major 100%
• Adverse Event 80%
• Substitution Therapy 80%
• Androgen Therapy 80%
• Iron Overload 20%
• Complication 20%
• Recurrent Disease 20%
• Chronic Liver Disease 20%
• Testosterone 20%
• Hypogonadism 20%
• Priapism 20%
• Persistent Pain 20%
• Injection Site 20%
• Gynecomastia 20%

Agricultural and Biological Sciences

• Testosterone 100%
• Iron Overload 20%
• Hypogonadism 20%
• Injection Site 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Hypogonadism 20%
• Priapism 20%